During the past decade, King Abdulaziz Medical city conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King Abdulaziz Medical city" #1 sponsor was "King Abdullah International Medical Research Center" with 6 trials, followed by "Actelion" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Janssen-Cilag Ltd." with 1 trials sponsored and "St. Joseph's Healthcare Hamilton" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Abdulaziz Medical city" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "King Abdulaziz University" with 1 trials as a collaborator, "King Abdullah International Medical Research Center" with 1 trials as a collaborator and "McMaster University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "King Abdulaziz Medical city" are "Critical Illness" (2 trials), "ARDS" (1 trials), "Bacteremia Caused by Gram-Negative Bacteria" (1 trials), "COVID-19" (1 trials) and "COVID19" (1 trials). Many other conditions were trialed in "King Abdulaziz Medical city" in a lesser frequency.

Most popular intervention types in "King Abdulaziz Medical city" are "Drug" (5 trials), "Other" (2 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Awake Proning" (1 trials), "Azacitidine" (1 trials), "Ceftolozane-Tazobactam" (1 trials) and "Cusatuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Abdulaziz Medical city" are 11 trials for "All" genders.

Currently, there are NaN active trials in "King Abdulaziz Medical city". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in King Abdulaziz Medical city, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in King Abdulaziz Medical city, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".